These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28039274)

  • 1. Population-based meta-analysis of roxithromycin pharmacokinetics: dosing implications of saturable absorption and protein binding.
    Dolton MJ; D'Argenio DZ
    J Antimicrob Chemother; 2017 Apr; 72(4):1129-1136. PubMed ID: 28039274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-linear absorption pharmacokinetics of amoxicillin: consequences for dosing regimens and clinical breakpoints.
    de Velde F; de Winter BC; Koch BC; van Gelder T; Mouton JW;
    J Antimicrob Chemother; 2016 Oct; 71(10):2909-17. PubMed ID: 27330071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population Pharmacokinetics and Pharmacodynamic Target Attainment of Ampicillin in Neonates with Hypoxemic-Ischemic Encephalopathy in the Setting of Controlled Hypothermia.
    Cies JJ; Fugarolas KN; Moore WS; Mason RW; Menkiti OR
    Pharmacotherapy; 2017 Apr; 37(4):456-463. PubMed ID: 28226400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of macrolides. Comparison of plasma, tissue and free concentrations with special reference to roxithromycin.
    Nilsen OG
    Infection; 1995; 23 Suppl 1():S5-9. PubMed ID: 7782117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single oral dose pharmacokinetics of erythromycin and roxithromycin and the effects of chronic dosing.
    Birkett DJ; Robson RA; Grgurinovich N; Tonkin A
    Ther Drug Monit; 1990 Jan; 12(1):65-71. PubMed ID: 2305423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roxithromycin Pharmacokinetics in Hospitalized Geriatric Patients: Oral Administration of Whole Versus Crushed Tablets.
    Britzi M; Berkovitch M; Soback S; Leibovitz A; Segal R; Smagarinsky M; Lubart E
    Ther Drug Monit; 2015 Aug; 37(4):512-5. PubMed ID: 26186658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Female genital tissue concentrations of roxithromycin.
    Furneri PM; Pinizzotto MR; Rugolo S; Cianci S; Cianci A; Tempera G
    J Chemother; 1991 Jan; 3 Suppl 1():30-2. PubMed ID: 12041780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic modelling of serum and bronchial concentrations for clarithromycin and telithromycin, and site-specific pharmacodynamic simulation for their dosages.
    Ikawa K; Kikuchi E; Kikuchi J; Nishimura M; Derendorf H; Morikawa N
    J Clin Pharm Ther; 2014 Aug; 39(4):411-7. PubMed ID: 24661290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis.
    Roberts JA; Kirkpatrick CM; Roberts MS; Dalley AJ; Lipman J
    Int J Antimicrob Agents; 2010 Feb; 35(2):156-63. PubMed ID: 20018492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of gatifloxacin and levofloxacin administered at various dosing regimens to hospitalised patients with community-acquired pneumonia: pharmacodynamic target attainment study using North American surveillance data for Streptococcus pneumoniae.
    Noreddin AM; Hoban DJ; Zhanel GG
    Int J Antimicrob Agents; 2005 Aug; 26(2):120-5. PubMed ID: 16046101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of pharmaceutical dosage forms on the pharmacokinetics of roxithromycin in healthy human volunteers.
    Sun J; Zhang T; Qiu F; Liu Y; Tang J; Huang H; He Z
    J Antimicrob Chemother; 2005 May; 55(5):796-9. PubMed ID: 15761061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics of oral levofloxacin 500 mg once-daily dosage in community-acquired lower respiratory tract infections: results of a prospective multicenter study in China.
    Zhang J; Xu JF; Liu YB; Xiao ZK; Huang JA; Si B; Sun SH; Xia QM; Wu XJ; Cao GY; Shi YG; Zhang YY
    J Infect Chemother; 2009 Oct; 15(5):293-300. PubMed ID: 19856067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units.
    Roos JF; Bulitta J; Lipman J; Kirkpatrick CM
    J Antimicrob Chemother; 2006 Nov; 58(5):987-93. PubMed ID: 16943209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetics and relative bioavailability study of roxithromycin tablet in Chinese healthy volunteers by LC-MS/MS].
    Zheng L; Qin Y; Nan F; Wang Y; Xu N; Liang M
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Dec; 26(6):1315-9. PubMed ID: 20095494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease in gastrointestinal absorption of roxithromycin in bile duct cannulated rats due to depletion of bile salts.
    Lee JH; Park YJ; Oh JH; Lee YJ
    Biopharm Drug Dispos; 2013 Sep; 34(6):360-4. PubMed ID: 23703541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of cefepime in febrile neutropenia: implications for dose-dependent susceptibility and contemporary dosing regimens.
    Rhodes NJ; Grove ME; Kiel PJ; O'Donnell JN; Whited LK; Rose DT; Jones DR; Scheetz MH
    Int J Antimicrob Agents; 2017 Sep; 50(3):482-486. PubMed ID: 28668694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetic modelling of total and unbound cefazolin plasma concentrations as a guide for dosing in preterm and term neonates.
    De Cock RF; Smits A; Allegaert K; de Hoon J; Saegeman V; Danhof M; Knibbe CA
    J Antimicrob Chemother; 2014 May; 69(5):1330-8. PubMed ID: 24492261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic target attainment analysis against Streptococcus pneumoniae using levofloxacin 500 mg, 750 mg and 1000 mg once daily in plasma (P) and epithelial lining fluid (ELF) of hospitalized patients with community acquired pneumonia (CAP).
    Noreddin AM; Marras TK; Sanders K; Chan CK; Hoban DJ; Zhanel GG
    Int J Antimicrob Agents; 2004 Nov; 24(5):479-84. PubMed ID: 15519481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: special emphasis on unbound pharmacokinetics.
    Ulldemolins M; Roberts JA; Wallis SC; Rello J; Lipman J
    J Antimicrob Chemother; 2010 Aug; 65(8):1771-8. PubMed ID: 20530507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetic-pharmacodynamic target attainment analysis of sulbactam in patients with impaired renal function: dosing considerations for Acinetobacter baumannii infections.
    Yokoyama Y; Matsumoto K; Ikawa K; Watanabe E; Morikawa N; Takeda Y
    J Infect Chemother; 2015 Apr; 21(4):284-9. PubMed ID: 25638291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.